Drug
Venglustat
Venglustat: highest development phase Phase 3, developed by Sanofi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Venglustat NCT07927140 | Phase 3 | Gaucher's Disease Type III |
Latest
No recent events.
Follow Venglustat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.